Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD Bank of England Statistics AD Investing.com Markets AD LSEG Data AD CME Group Education
Venues & MTFs

Propanc Reports Preclinical Data For PRP In Chemoresistance; Phase 1 Set For Q1 '27

Trade Hub UK regulation desk (2026-10-18): Propanc Reports Preclinical Data For PRP In Chemoresistance; Phase 1 Set For Q1 '27 (RTTNews) - Propanc Biopharma Inc. (PPCB), a biopharmaceutical company, on… Primary source: original at Nasdaq Market Structure (nasdaq.com).

By Nasdaq Market Structure

Propanc Reports Preclinical Data For PRP In Chemoresistance; Phase 1 Set For Q1 '27

(RTTNews) - Propanc Biopharma Inc. (PPCB), a biopharmaceutical company, on Friday announced preclinical data for a formulation of pancreatic pro-enzymes (PRP) in treating pancreatic and ovarian cancer.

Read at source

Read also
  1. Independent Bank: 3 Key Takeaways for Long-Term Investors
  2. Apple's Market Value Grew From $350 Billion to $5 Trillion During Tim Cook's 15 Years as CEO. Here's What That Growth Curve Means for Apple's Next Chapter Under John Ternus.
  3. Sugar Prices Sink on Forecasts for Drier Weather in Brazil
  4. How Nvidia Could Make $150 Billion Look Small
  5. Warren Buffett's Market Warning Is Hard to Ignore. But I'd Buy These 3 Stocks Anyway.

Source: Nasdaq Market Structure